Global Plasma Fractionation Market 2024-2028

The plasma fractionation market is forecasted to grow by USD 10.00 bn during 2023-2028, accelerating at a CAGR of 6.09% during the forecast period. The report on the plasma fractionation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of plasma products treated in respiratory diseases and AATD, a growing list of plasma-derived products, and an increase in M and A for producing plasma-based products.

Market Scope
Base Year	2023
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	5.81%
CAGR	6.09%
Incremental Value	$10.00bn

Technavio's plasma fractionation market is segmented as below:

By Product

Immunoglobulins
Albumin
Coagulation factor concentrates
Protease inhibitors
Others

By Application

Immunology
Neurology
Hematology
Critical care
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing elderly population and related disorders as one of the prime reasons driving the plasma fractionation market growth during the next few years. Also, government strategies for increasing self-sufficiency for plasma products and rising demand for plasma collection will lead to sizable demand in the market.

The report on the plasma fractionation market covers the following areas:

Plasma fractionation market sizing
Plasma fractionation market forecast
Plasma fractionation market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading plasma fractionation market vendors that include ADMA Biologics Inc., Bharat Serums and Vaccines Ltd., CSL Ltd., Emergent BioSolutions Inc., GC Biopharma corp. , Grifols SA, Hemarus Plasma, Intas Pharmaceuticals Ltd., Kamada Ltd., Kedrion S.p.A, LFB SA, Merck KGaA, Mitsubishi Chemical Group Corp., Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., Prothya Biosolutions Netherlands BV, Sanquin, SK Inc., Takeda Pharmaceutical Co. Ltd., and Virchow Laboratories Ltd.. Also, the plasma fractionation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR77166

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global plasma fractionation market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global plasma fractionation market 2018 - 2022 ($ billion)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
4.3 Application Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Immunoglobulins - Market size and forecast 2023-2028
Exhibit 34: Chart on Immunoglobulins - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Immunoglobulins - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Immunoglobulins - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Immunoglobulins - Year-over-year growth 2023-2028 (%)
6.4 Albumin - Market size and forecast 2023-2028
Exhibit 38: Chart on Albumin - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Albumin - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Albumin - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Albumin - Year-over-year growth 2023-2028 (%)
6.5 Coagulation factor concentrates - Market size and forecast 2023-2028
Exhibit 42: Chart on Coagulation factor concentrates - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Coagulation factor concentrates - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Coagulation factor concentrates - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Coagulation factor concentrates - Year-over-year growth 2023-2028 (%)
6.6 Protease inhibitors - Market size and forecast 2023-2028
Exhibit 46: Chart on Protease inhibitors - Market size and forecast 2023-2028 ($ billion)
Exhibit 47: Data Table on Protease inhibitors - Market size and forecast 2023-2028 ($ billion)
Exhibit 48: Chart on Protease inhibitors - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Protease inhibitors - Year-over-year growth 2023-2028 (%)
6.7 Others - Market size and forecast 2023-2028
Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.8 Market opportunity by Product
Exhibit 54: Market opportunity by Product ($ billion)
Exhibit 55: Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by Application

7.1 Market segments
Exhibit 56: Chart on Application - Market share 2023-2028 (%)
Exhibit 57: Data Table on Application - Market share 2023-2028 (%)
7.2 Comparison by Application
Exhibit 58: Chart on Comparison by Application
Exhibit 59: Data Table on Comparison by Application
7.3 Immunology - Market size and forecast 2023-2028
Exhibit 60: Chart on Immunology - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Immunology - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Immunology - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Immunology - Year-over-year growth 2023-2028 (%)
7.4 Neurology - Market size and forecast 2023-2028
Exhibit 64: Chart on Neurology - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Data Table on Neurology - Market size and forecast 2023-2028 ($ billion)
Exhibit 66: Chart on Neurology - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Neurology - Year-over-year growth 2023-2028 (%)
7.5 Hematology - Market size and forecast 2023-2028
Exhibit 68: Chart on Hematology - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Data Table on Hematology - Market size and forecast 2023-2028 ($ billion)
Exhibit 70: Chart on Hematology - Year-over-year growth 2023-2028 (%)
Exhibit 71: Data Table on Hematology - Year-over-year growth 2023-2028 (%)
7.6 Critical care - Market size and forecast 2023-2028
Exhibit 72: Chart on Critical care - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Data Table on Critical care - Market size and forecast 2023-2028 ($ billion)
Exhibit 74: Chart on Critical care - Year-over-year growth 2023-2028 (%)
Exhibit 75: Data Table on Critical care - Year-over-year growth 2023-2028 (%)
7.7 Others - Market size and forecast 2023-2028
Exhibit 76: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 78: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 79: Data Table on Others - Year-over-year growth 2023-2028 (%)
7.8 Market opportunity by Application
Exhibit 80: Market opportunity by Application ($ billion)
Exhibit 81: Data Table on Market opportunity by Application ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 83: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 84: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 85: Chart on Geographic comparison
Exhibit 86: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 87: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 91: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 95: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 99: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 103: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 107: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 108: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 109: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 113: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 115: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 116: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 117: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 118: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 119: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 120: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 121: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 122: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 123: Market opportunity By Geographical Landscape ($ billion)
Exhibit 124: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 125: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 126: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 127: Overview on factors of disruption
11.4 Industry risks
Exhibit 128: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 129: Vendors covered
12.2 Market positioning of vendors
Exhibit 130: Matrix on vendor position and classification
12.3 ADMA Biologics Inc.
Exhibit 131: ADMA Biologics Inc. - Overview
Exhibit 132: ADMA Biologics Inc. - Business segments
Exhibit 133: ADMA Biologics Inc. - Key offerings
Exhibit 134: ADMA Biologics Inc. - Segment focus
12.4 Bharat Serums and Vaccines Ltd.
Exhibit 135: Bharat Serums and Vaccines Ltd. - Overview
Exhibit 136: Bharat Serums and Vaccines Ltd. - Product / Service
Exhibit 137: Bharat Serums and Vaccines Ltd. - Key offerings
12.5 CSL Ltd.
Exhibit 138: CSL Ltd. - Overview
Exhibit 139: CSL Ltd. - Business segments
Exhibit 140: CSL Ltd. - Key offerings
Exhibit 141: CSL Ltd. - Segment focus
12.6 Emergent BioSolutions Inc.
Exhibit 142: Emergent BioSolutions Inc. - Overview
Exhibit 143: Emergent BioSolutions Inc. - Product / Service
Exhibit 144: Emergent BioSolutions Inc. - Key news
Exhibit 145: Emergent BioSolutions Inc. - Key offerings
12.7 GC Biopharma corp.
Exhibit 146: GC Biopharma corp. - Overview
Exhibit 147: GC Biopharma corp. - Product / Service
Exhibit 148: GC Biopharma corp. - Key offerings
12.8 Grifols SA
Exhibit 149: Grifols SA - Overview
Exhibit 150: Grifols SA - Business segments
Exhibit 151: Grifols SA - Key offerings
Exhibit 152: Grifols SA - Segment focus
12.9 Intas Pharmaceuticals Ltd.
Exhibit 153: Intas Pharmaceuticals Ltd. - Overview
Exhibit 154: Intas Pharmaceuticals Ltd. - Product / Service
Exhibit 155: Intas Pharmaceuticals Ltd. - Key offerings
12.10 Kedrion S.p.A
Exhibit 156: Kedrion S.p.A - Overview
Exhibit 157: Kedrion S.p.A - Product / Service
Exhibit 158: Kedrion S.p.A - Key offerings
12.11 LFB SA
Exhibit 159: LFB SA - Overview
Exhibit 160: LFB SA - Product / Service
Exhibit 161: LFB SA - Key offerings
12.12 Merck KGaA
Exhibit 162: Merck KGaA - Overview
Exhibit 163: Merck KGaA - Business segments
Exhibit 164: Merck KGaA - Key news
Exhibit 165: Merck KGaA - Key offerings
Exhibit 166: Merck KGaA - Segment focus
12.13 Mitsubishi Chemical Group Corp.
Exhibit 167: Mitsubishi Chemical Group Corp. - Overview
Exhibit 168: Mitsubishi Chemical Group Corp. - Business segments
Exhibit 169: Mitsubishi Chemical Group Corp. - Key offerings
Exhibit 170: Mitsubishi Chemical Group Corp. - Segment focus
12.14 Octapharma AG
Exhibit 171: Octapharma AG - Overview
Exhibit 172: Octapharma AG - Product / Service
Exhibit 173: Octapharma AG - Key offerings
12.15 Sanquin
Exhibit 174: Sanquin - Overview
Exhibit 175: Sanquin - Product / Service
Exhibit 176: Sanquin - Key offerings
12.16 SK Inc.
Exhibit 177: SK Inc. - Overview
Exhibit 178: SK Inc. - Product / Service
Exhibit 179: SK Inc. - Key offerings
12.17 Takeda Pharmaceutical Co. Ltd.
Exhibit 180: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 181: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 182: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 183: Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 184: Inclusions checklist
Exhibit 185: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 186: Currency conversion rates for US$
13.4 Research methodology
Exhibit 187: Research methodology
Exhibit 188: Validation techniques employed for market sizing
Exhibit 189: Information sources
13.5 List of abbreviations
Exhibit 190: List of abbreviations